sativex oromucos. spray sol. spray cont.
gw pharma (international) b.v. - cannabis sativa l., leaf, flower, soft extract - eq. cannabidiol (cbd) 2,5 mg/dose; cannabis sativa l., leaf, flower, soft extract - eq. delta-9-tetrahydrocannabinol (thc) 2,7 mg/dose - oromucosal spray, solution - cannabis sativa l., leaf, flower, soft extract; cannabis sativa l., leaf, flower, soft extract - cannabinoids
nasative 500mcg/ml nasal spray suspension
n/a; importer: h & b pharma international, inc.; distributor: h & b pharma international, inc. - mometasone furoate - nasal spray suspension - 500mcg/ml
vancomycin
generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 1000 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins.
vancomycin
generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 500 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins
ciprofloxacin 2mg/ml, solution for infusion
baxter holding b.v. - ciprofloxacin lactate - solution for infusion - 2 milligram(s)/millilitre - fluoroquinolones; ciprofloxacin
vancomycin 1000 mg powder for concentrate for solution for infusion
hikma farmacêutica (portugal) s.a. - vancomycin hydrochloride - powder for concentrate for solution for infusion - 1 gram(s) - glycopeptide antibacterials; vancomycin
vancomycin 500 mg powder for concentrate for solution for infusion
hikma farmacêutica (portugal) s.a. - vancomycin hydrochloride - powder for concentrate for solution for infusion - 500 milligram(s) - glycopeptide antibacterials; vancomycin
avena sativea liquid
german pharmaceuticals (homoeo) - avena sativa - liquid
meropenem kabi meropenem (as trihydrate) 1 g powder for injection vials
fresenius kabi australia pty ltd - meropenem trihydrate, quantity: 1140 mg (equivalent: meropenem, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - indications,meropenem kabi is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,? community acquired lower respiratory tract infection ,? hospital acquired lower respiratory tract infection,? complicated urinary tract infection,? febrile neutropaenia,? intra-abdominal and gynaecological (poly microbial) infections,? complicated skin and skin structure infections,? meningitis,? septicaemia